Get started
Author

Andromachi Vryonidou

Observed names: A Vryonidou, A. Vryonidou, ANDROMACHI VRYONIDOU, M. Vryonidou, Vryonidou, Andromachi
Observed institutions: Agricultural University of Athens, National Institutes of Health, Democritus University of Thrace, Parthenope University of Naples, National and Kapodistrian University of Athens, Aristotle University of Thessaloniki, Hellenic Red Cross, Red Cross Hospital, Children's Hospital Agia Sophia, St Savas Hospital, Simanogleio-Amalia Fleming General Hospital, Athens Medical Center, AOU San Giovanni di Dio e Ruggi d'Aragona, University General Hospital Attikon, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Hippocration General Hospital
ORCID: 0000-0002-0544-5952
Observed ORCID: 0000-0002-0544-5952
OpenAlex ID: A5036093625
Hypokalemia: a clinical update
2018 · Efstratios Kardalas, Stavroula A Paschou, et al. · Endocrine Connections · 390
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome
2019 · Stavroula A. Paschou, Stergios A. Polyzos, et al. · Endocrine · 231
Type 2 Diabetes and Osteoporosis: A Guide to Optimal Management
2017 · Stavroula Α Paschou, Anastasia D Dede, et al. · The Journal of Clinical Endocrinology & Metabolism · 206
PDF
Early onset type 2 diabetes mellitus: an update
2024 · Myrsini Strati, Melpomeni Moustaki, et al. · Endocrine · 175
PDF
Association of Hyperandrogenemic and Metabolic Phenotype with Carotid Intima-Media Thickness in Young Women with Polycystic Ovary Syndrome
2005 · Andromachi Vryonidou, Athanasios Papatheodorou, et al. · The Journal of Clinical Endocrinology & Metabolism · 172
Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
2009 · E. Vassilatou, S. Lafoyianni, et al. · Human Reproduction · 145
Th1 and Th2 Serum Cytokine Profiles Characterize Patients with Hashimoto’s Thyroiditis (Th1) and Graves’ Disease (Th2)
2004 · Costas Phenekos, Andromachi Vryonidou, et al. · NeuroImmunoModulation · 143
Hypertension in patients with type 2 diabetes mellitus: Targets and management
2018 · Dimitra I. Pavlou, Stavroula A. Paschou, et al. · Maturitas · 113
Hormonal activity of adrenal incidentalomas: results from a long‐term follow‐up study
2008 · E. Vassilatou, A. Vryonidou, et al. · Clinical Endocrinology · 113
MECHANISMS IN ENDOCRINOLOGY: Aging and anti-aging: a Combo-Endocrinology overview
2017 · Evanthia Diamanti-Kandarakis, Maurizio Dattilo, et al. · European Journal of Endocrinology · 105
MECHANISMS IN ENDOCRINOLOGY: Metabolic syndrome through the female life cycle
2015 · Andromachi Vryonidou, Stavroula A Paschou, et al. · European Journal of Endocrinology · 90
Thyroid nodules: Α guide to assessment, treatment and follow-up
2016 · Stavroula Α. Paschou, Andromachi Vryonidou, et al. · Maturitas · 87
Presence of immunoreactive corticotropin-releasing hormone in normal and polycystic human ovaries
1994 · G Mastorakos, C D Scopa, et al. · The Journal of Clinical Endocrinology & Metabolism · 81
Presence of immunoreactive corticotropin-releasing hormone in human endometrium
1996 · G Mastorakos, C D Scopa, et al. · The Journal of Clinical Endocrinology & Metabolism · 78
Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review
2018 · Panagiotis Anagnostis, Stavroula A. Paschou, et al. · Endocrine · 71
Diabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes?
2016 · Maria Mizamtsidi, Stavroula A. Paschou, et al. · European Journal of Clinical Investigation · 71
Diabetes in Menopause: Risks and Management
2018 · Stavroula Α. Paschou, Panagiotis Anagnostis, et al. · Current Vascular Pharmacology · 64
Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications
2014 · Evangeline Vassilatou, Andromachi Vryonidou, et al. · European Journal of Endocrinology · 63
Secondary diabetes mellitus in acromegaly
2023 · Melpomeni Moustaki, Stavroula A. Paschou, et al. · Endocrine · 44
PDF
Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome
2018 · Evangeline Vassilatou, Sophia Lafoyianni, et al. · Maturitas · 43
Is cardiovascular risk in women with PCOS a real risk? Current insights
2017 · Georgios Papadakis, Eleni Kandaraki, et al. · Minerva Endocrinology · 40
Favorable Effect of Anti-TNF Therapy on Insulin Sensitivity in Nonobese, Nondiabetic Patients with Inflammatory Bowel Disease
2018 · Stavroula A. Paschou, Fotios Kothonas, et al. · International Journal of Endocrinology · 37
PDF
Food Cravings and Obesity in Women with Polycystic Ovary Syndrome: Pathophysiological and Therapeutic Considerations
2024 · Katerina Stefanaki, Dimitrios S. Karagiannakis, et al. · Nutrients · 32
PDF
Secondary diabetes mellitus due to primary aldosteronism
2022 · Melpomeni Moustaki, Stavroula A. Paschou, et al. · Endocrine · 30
Biological therapies for premature ovarian insufficiency: what is the evidence?
2023 · Melpomeni Moustaki, Adamantia Kontogeorgi, et al. · Frontiers in Reproductive Health · 29
PDF
Works count: 123
Citation count: 3,239
H-index: 27
I10-index: 51
Year
Topic
Type